Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin eye drops for vernal keratoconjunctivitis
ChiCTR-IPC-14005386Phase 4Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of heparin in Vernal Keratoconjunctivitis (VKC) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Efficacy of heparin eye drops on objective signs and ocular symptoms. Started Nov 2014; status: recruiting.
02
Drugs
heparin
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on ChiCTR-IPC-14005386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-14005386.